Elevance Health (ELV) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Elevance Health · Health Care · ref. ETF XLV · 63 calls · price $399.11
What the company does: Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
📈 Elevance Health (ELV) stock price
$399.11+28.6% over range
Aug 28, 25low $280.74 · high $426.79Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
72% recommend buying · 18 analysts
📊 JPI status : Elevance Health is no longer in our current JPI rankings, but appeared in the past (2020) — its upside may be behind it. See the stocks picked in 2020 →
🎯 ELV price target & analyst consensus — price $399
The price target · all analysts combined (18 targets)
Highest target · 1 firm of 18$498+24.8%
Median target · of 18 targets$458.5+14.9%
Lowest target · 1 firm of 18$360-9.8%
Current price$399.11
Where these 18 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1478%
$404 ↔ $498
Below
422%
$360 ↔ $395
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $404 (+1.2 %), call made on June 5, 2026, maturing on June 5, 2027 (84 d ago).
The 12 reliable analysts
$463+16 %
The 6 other firms
$437+9.5 %
How to read it: the 12 reliable firms are not filtered by optimism — 10 aim above the price, 2 below, hence their $463 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 18 ratings (last 6 months)
Strong Buy00%
Buy1372%
Hold528%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 ELV price target all
All 17 calls, one by one, with our verdict on each firm.
→ See all 17 targets, analyst by analyst💡 The best analysts on ELV most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ELV? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Elevance Health? The JPI assistant answers using our backtest data.
💰 Elevance Health dividend: yield, history & growth › open the full page
1.65%annual yield
📈 Steady dividend — 14 yrs of consecutive dividend increases
That's ~$6.86 per share per year.
📈 Elevance Health fundamentals: valuation, margins & growth › open the full page
P/E 17.8Net margin 2.5 %Revenue growth +1.4 %Average P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 4 %
2023
Rev +9%Profit −1%
2024
Rev +3%Profit −0%
2025
Rev +13%Profit −5%
🏛️ Elevance Health insider buying: who's buying and how much › open the full page
3 insiders bought3 buys / 6 mo $2.2M👥 Cluster buy
🔎 Detailed analyses
🏛️ Which US Congress members hold Elevance Health (ELV)?
3 Congress members have disclosed ELV buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on ELV
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Bank of America | 100% | +28.4% | 2 |
| Leerink Swann | 100% | +22.9% | 2 |
| Credit Suisse | 80% | +14.1% | 10 |
| BMO Capital ↗ | 75% | +6.5% | 4 |
| Stephens & Co. ↗ | 75% | +4.3% | 8 |
| Morgan Stanley ↗ | 70% | +10.8% | 23 |
| Jefferies ↗ | 70% | +10.4% | 10 |
| SVB Leerink | 67% | +28.1% | 6 |
| Deutsche Bank ↗ | 67% | +11.7% | 9 |
| UBS ↗ | 62% | +10.1% | 8 |
See the other 14 firms
| B of A Securities ↗ | 0% | -19.3% | 2 |
| Oppenheimer ↗ | 0% | -8.0% | 2 |
| Cantor Fitzgerald ↗ | 14% | -16.5% | 22 |
| Mizuho ↗ | 20% | -13.0% | 5 |
| Argus Research ↗ | 33% | -13.3% | 3 |
| Guggenheim ↗ | 33% | -3.4% | 3 |
| RBC Capital ↗ | 45% | -4.4% | 11 |
| Wells Fargo ↗ | 47% | +2.7% | 15 |
| TD Cowen ↗ | 50% | -9.5% | 4 |
| Goldman Sachs ↗ | 50% | -3.0% | 2 |
| Cowen & Co. | 50% | +15.7% | 4 |
| Truist Securities ↗ | 55% | +2.5% | 11 |
| Barclays ↗ | 61% | +3.0% | 18 |
| JP Morgan ↗ | 62% | +1.0% | 8 |
📊 What $1,000 invested in Elevance Health would be worth › open the full page
In short — $1,000 invested in Elevance Health 10 years ago would be worth $2,773 today, i.e. +11%/yr on average. Best year: 2017 (+57%), worst: 2024 (-22%). Price performance, excluding dividends.
If I'd invested $1,000 in Elevance Health
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,048 | +5% |
| 3 years ago | $754 | -25% |
| 5 years ago | $1,204 | +20% |
Return by year (Elevance Health)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +10% | $1,103 (+10%) |
| 2025 | -5% | $1,048 (+5%) |
| 2024 | -22% | $820 (-18%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Elevance Health
Loading news…
📋 All analyst calls on ELV
Filtered on — · ✕ show all
Leerink Partners ↗
Jul 17, 26
■ Market Perform neutral · not a buy · 🎯$395
Price at call : $382.23 — gap to target +3%
Today : $399.11 — gap to target -1%
🎯 on ELV : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
RBC Capital ↗
Jul 16, 26
■ Sector Perform neutral · not a buy · 🎯$424
Price at call : $373.11 — gap to target +14%
Today : $399.11 — gap to target +6%
🎯 on ELV : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
Wells Fargo ↗
Jul 16, 26
▲ Overweight · 🎯$473
Price at call : $373.11 — upside +27%
Today : $399.11 — upside +19%
🎯 on ELV : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
Guggenheim ↗
Jul 16, 26
▲ Buy · 🎯$455
Price at call : $372.85 — upside +22%
Today : $399.11 — upside +14%
🎯 on ELV : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Overweight · 🎯$457
Price at call : $372.85 — upside +23%
Today : $399.11 — upside +15%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
■ Neutral neutral · not a buy · 🎯$393
Price at call : $372.85 — gap to target +5%
Today : $399.11 — gap to target -2%
🎯 on ELV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Buy · 🎯$465
Price at call : $390.33 — upside +19%
Today : $399.11 — upside +17%
🎯 on ELV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Truist Securities ↗
Jul 14, 26
▲ Buy · 🎯$475
Price at call : $390.33 — upside +22%
Today : $399.11 — upside +19%
🎯 on ELV : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
See the other 55 calls, newest to oldest
Wells Fargo ↗
Jul 13, 26
▲ Overweight · 🎯$492
Price at call : $426.79 — upside +15%
Today : $399.11 — upside +23%
🎯 on ELV : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
RBC Capital ↗
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$439
Price at call : $416.23 — gap to target +5%
Today : $399.11 — gap to target +10%
🎯 on ELV : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Cantor Fitzgerald ↗
Jul 7, 26
▲ Overweight · 🎯$450
Price at call : $418.85 — upside +7%
Today : $399.11 — upside +13%
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
▲ Outperform · 🎯$482
Price at call : $408.17 — upside +18%
Today : $399.11 — upside +21%
🎯 on ELV : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jul 2, 27
matures : Jul 2, 27
▲ Outperform · 🎯$465
Price at call : $424.43 — upside +10%
Today : $399.11 — upside +17%
🎯 on ELV : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
▲ Overweight · 🎯$476
Price at call : $424.43 — upside +12%
Today : $399.11 — upside +19%
🎯 on ELV : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
B of A Securities ↗
Jun 4, 26
▲ Buy · 🎯$460
Price at call : $415.53 — upside +11%
Today : $399.11 — upside +15%
🎯 on ELV : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Morgan Stanley ↗
Jun 4, 26
■ Equal-Weight neutral · not a buy · 🎯$404
Price at call : $415.53 — gap to target -3%
Today : $399.11 — gap to target +1%
🎯 on ELV : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
Truist Securities ↗
Jun 1, 26
▲ Buy · 🎯$450
Price at call : $389.03 — upside +16%
Today : $399.11 — upside +13%
🎯 on ELV : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jun 1, 27
matures : Jun 1, 27
▲ Overweight · 🎯$480
Price at call : $391.47 — upside +23%
Today : $399.11 — upside +20%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
▲ Buy · 🎯$460
Price at call : $387.85 — upside +19%
Today : $399.11 — upside +15%
🎯 on ELV : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
▲ Outperform · 🎯$435
Price at call : $396.21 — upside +10%
Today : $399.11 — upside +9%
🎯 on ELV : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
Deutsche Bank ↗
May 20, 26
▲ Buy · 🎯$498
Price at call : $396.21 — upside +26%
Today : $399.11 — upside +25%
🎯 on ELV : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : May 20, 27
matures : May 20, 27
B of A Securities ↗
Apr 29, 26
▲ Buy · 🎯$435
Price at call : $376.63 — upside +15%
Today : $399.11 — upside +9%
🎯 on ELV : no call matured yet · 📊 on Health : 48.3% · +2.0% (356 calls)
in progress (365j)
matures : Apr 29, 27
matures : Apr 29, 27
▲ Overweight · 🎯$411
Price at call : $376.63 — upside +9%
Today : $399.11 — upside +3%
🎯 on ELV : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Apr 28, 27
matures : Apr 28, 27
▲ Overweight · 🎯$408
Price at call : $356.13 — upside +15%
Today : $399.11 — upside +2%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Guggenheim ↗
Apr 24, 26
▲ Buy · 🎯$399
Price at call : $356.13 — upside +12%
Today : $399.11 — upside -0%
🎯 on ELV : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▲ Outperform · 🎯$424
Price at call : $356.13 — upside +19%
Today : $399.11 — upside +6%
🎯 on ELV : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Evercore ISI Group ↗
Apr 23, 26
■ In-Line neutral · not a buy · 🎯$360
Price at call : $344.76 — gap to target +4%
Today : $399.11 — gap to target -10%
🎯 on ELV : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
■ Neutral neutral · not a buy · 🎯$331
Price at call : $346.29 — gap to target -4%
Today : $399.11 — gap to target -17%
🎯 on ELV : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$391
Price at call : $328.11 — upside +19%
Today : $399.11 — upside -2%
🎯 on ELV : no call matured yet · 📊 on Health : 50.8% · +4.5% (380 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
Truist Securities ↗
Apr 13, 26
▲ Buy · 🎯$375
Price at call : $313.35 — upside +20%
Today : $399.11 — upside -6%
🎯 on ELV : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 8, 26
■ In-Line neutral · not a buy · 🎯$345
Price at call : $318.23 — gap to target +8%
Today : $399.11 — gap to target -14%
🎯 on ELV : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
▲ Outperform · 🎯$350
Price at call : $289.79 — upside +21%
Today : $399.11 — upside -12%
🎯 on ELV : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
▲ Overweight · 🎯$397
Price at call : $338.65 — upside +17%
Today : $399.11 — upside -1%
🎯 on ELV : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
▲ Outperform · 🎯$409
Price at call : $338.65 — upside +21%
Today : $399.11 — upside +2%
🎯 on ELV : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Truist Securities ↗
Feb 2, 26
▲ Buy · 🎯$390
Price at call : $341.83 — upside +14%
Today : $399.11 — upside -2%
🎯 on ELV : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
▲ Overweight · 🎯$393
Price at call : $341.83 — upside +15%
Today : $399.11 — upside -2%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
Wells Fargo ↗
Jan 30, 26
▲ Overweight · 🎯$391
Price at call : $341.83 — upside +14%
Today : $399.11 — upside -2%
🎯 on ELV : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
Guggenheim ↗
Jan 29, 26
▲ Buy · 🎯$396
Price at call : $345.74 — upside +15%
Today : $399.11 — upside -1%
🎯 on ELV : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jan 29, 27
matures : Jan 29, 27
Guggenheim ↗
Jan 22, 26
▲ Buy · 🎯$414
Price at call : $372.24 — upside +11%
Today : $399.11 — upside +4%
🎯 on ELV : no call matured yet · 📊 on Health : 54.6% · +4.4% (97 calls)
in progress (365j)
matures : Jan 22, 27
matures : Jan 22, 27
Wolfe Research ↗
Jan 8, 26
▲ Outperform · 🎯$425
Price at call : $374.77 — upside +13%
Today : $399.11 — upside +6%
🎯 on ELV : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Wells Fargo ↗
Jan 7, 26
▲ Overweight · 🎯$424
Price at call : $374.77 — upside +13%
Today : $399.11 — upside +6%
🎯 on ELV : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
▲ Overweight · 🎯$404
Price at call : $363.51 — upside +11%
Today : $399.11 — upside +1%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Deutsche Bank ↗
Dec 19, 25
■ Hold neutral · not a buy · 🎯$320
Price at call : $344.27 — gap to target -7%
Today : $399.11 — gap to target -20%
🎯 on ELV : no call matured yet · 📊 on Health : 53.3% · +4.5% (291 calls)
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
Morgan Stanley ↗
Dec 18, 25
■ Equal-Weight neutral · not a buy · 🎯$352
Price at call : $340.69 — gap to target +3%
Today : $399.11 — gap to target -12%
🎯 on ELV : no call matured yet · 📊 on Health : 51.5% · +5.2% (825 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Buy · 🎯$400
Price at call : $338.26 — upside +18%
Today : $399.11 — upside +0%
🎯 on ELV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Nov 26, 26
matures : Nov 26, 26
▲ Outperform · 🎯$400
Price at call : $316.62 — upside +26%
Today : $399.11 — upside +0%
🎯 on ELV : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Nov 4, 26
matures : Nov 4, 26
▲ Overweight · 🎯$394
Price at call : $339.4 — upside +16%
Today : $399.11 — upside -1%
🎯 on ELV : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Buy · 🎯$380
Price at call : $342.35 — upside +11%
Today : $399.11 — upside -5%
🎯 on ELV : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
Wells Fargo ↗
Oct 22, 25
▲ Overweight · 🎯$403
Price at call : $345.21 — upside +17%
Today : $399.11 — upside +1%
🎯 on ELV : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
▲ Overweight · 🎯$385
Price at call : $345.21 — upside +12%
Today : $399.11 — upside -4%
🎯 on ELV : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
Leerink Partners ↗
Jul 18, 25
■ Market Perform neutral · not a buy · 🎯$310
Price at call : $277.09 — gap to target +12%
Today : $399.11 — gap to target -22%
🎯 on ELV : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jul 18, 26
matures : Jul 18, 26
Cantor Fitzgerald ↗
Apr 23, 25
▲ Overweight · 🎯$485
Price at call : $428.79 — upside +13%
Today : $399.11 — upside +22%
Expected +13% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-19.6%
stock -20% · XLV +5%
matured Apr 23, 26
Cantor Fitzgerald ↗
Jan 24, 25
▲ Overweight · 🎯$485
Price at call : $411.24 — upside +18%
Today : $399.11 — upside +22%
Expected +18% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-8.3%
stock -8% · XLV +7%
matured Jan 24, 26
Cantor Fitzgerald ↗
Oct 18, 24
▲ Overweight · 🎯$485
Price at call : $430.77 — upside +13%
Today : $399.11 — upside +22%
Expected +13% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-17.8%
stock -18% · XLV -5%
matured Oct 18, 25
Cantor Fitzgerald ↗
Oct 1, 24
▲ Overweight · 🎯$600
Price at call : $505.16 — upside +19%
Today : $399.11 — upside +50%
Expected +19% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-32.6%
stock -33% · XLV -6%
matured Oct 1, 25
Cantor Fitzgerald ↗
Sep 20, 24
▲ Overweight · 🎯$600
Price at call : $533.9 — upside +12%
Today : $399.11 — upside +50%
Expected +12% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-40.5%
stock -40% · XLV -12%
matured Sep 20, 25
Cantor Fitzgerald ↗
Sep 10, 24
▲ Overweight · 🎯$600
Price at call : $543.39 — upside +10%
Today : $399.11 — upside +50%
Expected +10% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-42.0%
stock -42% · XLV -10%
matured Sep 10, 25
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$600
Price at call : $543.04 — upside +10%
Today : $399.11 — upside +50%
Expected +10% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-42.9%
stock -43% · XLV -11%
matured Aug 19, 25
Cantor Fitzgerald ↗
Jul 23, 24
▲ Overweight · 🎯$600
Price at call : $512.12 — upside +17%
Today : $399.11 — upside +50%
Expected +17% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-45.2%
stock -45% · XLV -9%
matured Jul 23, 25
Cantor Fitzgerald ↗
Jul 10, 24
▲ Overweight · 🎯$600
Price at call : $533.82 — upside +12%
Today : $399.11 — upside +50%
Expected +12% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-36.2%
stock -36% · XLV -8%
matured Jul 10, 25
Cantor Fitzgerald ↗
Jun 12, 24
▲ Overweight · 🎯$600
Price at call : $538.75 — upside +11%
Today : $399.11 — upside +50%
Expected +11% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-28.6%
stock -29% · XLV -7%
matured Jun 12, 25
Cantor Fitzgerald ↗
Apr 10, 24
▲ Overweight · 🎯$580
Price at call : $501.96 — upside +16%
Today : $399.11 — upside +45%
Expected +16% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-12.4%
stock -12% · XLV -3%
matured Apr 10, 25
Cantor Fitzgerald ↗
Apr 4, 24
▲ Overweight · 🎯$580
Price at call : $507.35 — upside +14%
Today : $399.11 — upside +45%
Expected +14% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on ELV : 0% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (342 calls)
-16.6%
stock -17% · XLV -6%
matured Apr 4, 25
Frequently asked questions
Should I buy Elevance Health stock?
This isn't buy advice. For Elevance Health, the analyst consensus is "Buy", with an average price target of $459 (+15% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Elevance Health). We show the numbers — you decide.
Is it too late to buy Elevance Health? How high can it go?
The most bullish analyst target on Elevance Health is $498 (+25% above today's price); the average is $459. That's the upside they see. Check how reliable those analysts have actually been on Elevance Health on our site before trusting it.
Is Elevance Health still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 24 analysts have a real record on Elevance Health, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Elevance Health? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ELV (and why hesitate).
What has Elevance Health's past performance been?
Historical returns and a "how much if I had invested" calculator: ELV performance & returns.
Does Elevance Health pay a dividend?
Yield, consistency and growth history of the dividend: ELV's dividend.
What is the best month to buy ELV?
The 12 months ranked by the stock's past returns: best & worst month to buy ELV.
Are insiders buying ELV stock?
Executives' and large holders' buys and sells, decoded: insider buying on ELV.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX